Stilbene Biopharma Profile
Key Indicators
- Authorised Capital ₹ 9.90 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.17 Cr
- Satisfied Charges ₹ 5.43 Cr
- Revenue Growth -27.77%
- Profit Growth -44.53%
- Ebitda -41.69%
- Net Worth 36.64%
- Total Assets -0.96%
About Stilbene Biopharma
Stilbene Biopharma Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 June 2005 and has a history of 19 years and eight months. Its registered office is in Godavari, Andhra Pradesh, India.
The Corporate was formerly known as Stilbene Biopharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.90 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹5.17 Cr. The company has closed loans amounting to ₹5.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jogeswararao Vegulla, Mutyala Rao, and Mutyala Prasad serve as directors at the Company.
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U45200AP2005PTC046614
- Company No.
046614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2005
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Stilbene Biopharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jogeswararao Vegulla  | Director | 27-Sep-2006 | Current |
| Mutyala Rao | Director | 22-Jun-2005 | Current |
| Mutyala Prasad | Director | 22-Jul-2014 | Current |
Financial Performance of Stilbene Biopharma.
Stilbene Biopharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 27.77% decrease. The company also saw a substantial fall in profitability, with a 44.53% decrease in profit. The company's net worth Soared by an impressive increase of 36.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stilbene Biopharma?
Unlock access to Stilbene Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Surya Chandra Paper Mills Private LimitedJogeswararao Vegulla, Mutyala Rao and 1 more are mutual person
Charges (Loans)
₹5.17 Cr
₹5.43 Cr
Charges Breakdown by Lending Institutions
- Others : 5.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2018 | Others | ₹5.17 Cr | Open |
| 10 Feb 2021 | Others | ₹6.30 M | Satisfied |
| 10 Feb 2021 | Others | ₹2.00 M | Satisfied |
| 03 Aug 2009 | Others | ₹4.60 Cr | Satisfied |
How Many Employees Work at Stilbene Biopharma?
Stilbene Biopharma has a workforce of 47 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stilbene Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stilbene Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
